Karen Noblett, Chief Medical Officer at Axonics, Inc. (AXNX), sold 15,999 shares at $69.00 ($1.1M) on 2024-01-08, disclosed to the SEC on 2024-01-10.
Scheduled sale ($1.1M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AXNX | SELL | 2023-02-02 | $510K | — | Filing → |
| AXNX | SELL | 2022-09-20 | $5.1M | — | Filing → |
| AXNX | SELL | 2022-09-09 | $1.5M | — | Filing → |